IL6 and cancer: In the A549 cancer cell line, senescence-related IL-6 promotes the methylation of p53 and p21 by increasing cellular DNMT1 expression [66], which helps to suppress the weakening of the influence of necessary senescence regulatory factors and promotes the formation of a cancer stem phenotype.